Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
Markets
Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
Filecoin declines as crypto markets retreat
Markets
Share
Share this article
Copy linkX (Twitter)LinkedInFacebookEmail
Filecoin declines as crypto markets retreat
Filecoin declines as crypto markets retreat
Filecoin declines as crypto markets retreat
FIL has support at the $1.52 level and resistance in the $1.59-$1.60 zone.
By Will Canny, CD Analytics|Edited by Cheyenne Ligon
Jan 7, 2026, 2:22 p.m.
Make us preferred on Google
Filecoin declines as crypto markets retreat.
What to know:
- FIL slipped 3.6% to $1.54.
- The CoinDesk 20 index was 3.6% lower at publication time.
Storage token Filecoin FIL$1.5439 fell 3.6% over the last 24 hours, tracking weakness in the wider cryptocurrency market.
The broader market gauge, the CoinDesk 20 index, was also 3.6% lower at publication time.
STORY CONTINUES BELOW
Don't miss another story.Subscribe to the Crypto Daybook Americas Newsletter today. See all newsletters
Sign me up
Filecoin's volume ran 30% above the 30-day moving average, though participation failed to breach elevated thresholds that typically confirm directional conviction, according to CoinDesk Research's technical analysis model.
The model showed that the token exhibited range-bound volatility. Total range measured $0.08 (5.0%) with a session high of $1.61 and low of $1.52.
The most significant volume event materialized yesterday evening when participation spiked to 7.30 million, 95% above the 24-hour simple moving average of 3.74 million, according to the model.
This spike coincided with sharp downside rejection from resistance near $1.60 and established critical support at $1.52, the model said.
The model showed that price subsequently recovered to retest the $1.59-$1.60 resistance zone multiple times on declining volume, forming a consolidation pattern with support holding above $1.55 through the final hours.
Technical Analysis:
- Primary resistance: $1.59-$1.60 zone tested multiple times on declining volume, indicating exhaustion
- Critical support: $1.52 established during spike low with 7.30 million volume
- 24-hour participation: 30% above 30-day moving average, below elevated interest threshold
- Failed breakout: Two-minute whipsaw from $1.561 to $1.57 and back suggests algorithmic activity
- Declining volume retests: Multiple attempts at $1.59-$1.60 resistance on diminishing participation
- Downside risk: Support breakdown below $1.52 exposes limited technical structure
Disclaimer: Parts of this article were generated with the assistance from AI tools and reviewed by our editorial team to ensure accuracy and adherence to our standards. For more information, see CoinDesk's full AI Policy.
AI Market InsightsFilecoinTechnical Analysis
More For You
KuCoin Hits Record Market Share as 2025 Volumes Outpace Crypto Market
Commissioned byKuCoin
KuCoin captured a record share of centralised exchange volume in 2025, with more than $1.25tn traded as its volumes grew faster than the wider crypto market.
What to know:
- KuCoin recorded over $1.25 trillion in total trading volume in 2025, equivalent to an average of roughly $114 billion per month, marking its strongest year on record.
- This performance translated into an all-time high share of centralised exchange volume, as KuCoin’s activity expanded faster than aggregate CEX volumes, which slowed during periods of lower market volatility.
- Spot and derivatives volumes were evenly split, each exceeding $500 billion for the year, signalling broad-based usage rather than reliance on a single product line.
- Altcoins accounted for the majority of trading activity, reinforcing KuCoin’s role as a primary liquidity venue beyond BTC and ETH at a time when majors saw more muted turnover.
- Even as overall crypto volumes softened mid-year, KuCoin maintained elevated baseline activity, indicating structurally higher user engagement rather than short-lived volume spikes.
View Full Report
More For You
Rumble introduces crypto wallet with Tether, allowing tips in BTC, USDT, XAUT
Integrated into the Rumble app, the non-custodial wallet allows fans to tip content producers.
What to know:
- Rumble has launched a non-custodial crypto wallet in partnership with Tether, allowing users to tip creators in BTC, USDT, and XAUt.
- The Rumble Wallet is the first live deployment of Tether’s Wallet Development Kit and keeps user custody fully decentralized.
- The feature, integrated into the Rumble app and powered by MoonPay, adds a new income stream for creators outside ads or subscriptions.
Read full story
Latest Crypto News
Former Brazil central bank official unveils real-pegged stablecoin with yield sharing
CoinDesk 20 Performance Update: Uniswap (UNI) Falls 1.5% as Index Trades Lower
Rumble introduces crypto wallet with Tether, allowing tips in BTC, USDT, XAUT
Babylon Labs raises $15 million from a16z crypto to develop Bitcoin collateral infrastructure
Ripple again rules out IPO, saying balance sheet gives it room to stay private
Strategy’s STRC perpetual preferred stock returns to $100, may trigger more bitcoin buying
Top Stories
Crypto Markets Today: Bitcoin slides as Asia-led sell-off hits altcoins
Morgan Stanley files for ether trust after bitcoin and solana ETF push
Ripple again rules out IPO, saying balance sheet gives it room to stay private
Bitcoin miners chase AI demand as Nvidia says Rubin is already in production
XRP could outperform bitcoin as XRP/BTC chart shows rare Ichimoku breakout since 2018
Start-of-the-year recovery rally stalls: Crypto Daybook Americas
Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
You May Also Like
Trump Filed a Lawsuit Against JPMorgan Chase And Its CEO Over Debanking
U.S. President Donald Trump filed a lawsuit against JPMorgan Chase and its CEO Jamie Dimon personally, accusing the institution of deliberate debanking. The politician
Share
Incrypted2026/01/23 15:59
Here’s why Polygon price is at risk of a 25% plunge
Polygon price continued its freefall, reaching its lowest level since April 21, as the broader crypto sell-off gained momentum. Polygon (POL) dropped to $0.1915, down 32% from its highest point in May and 74% below its 2024 peak. The crash…
Share
Crypto.news2025/06/19 00:56
Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution
The post Non-Opioid Painkillers Have Struggled–Cannabis Drugs Might Be The Solution appeared on BitcoinEthereumNews.com. In this week’s edition of InnovationRx, we look at possible pain treatments from cannabis, risks of new vaccine restrictions, virtual clinical trials at the Mayo Clinic, GSK’s $30 billion U.S. manufacturing commitment, and more. To get it in your inbox, subscribe here. Despite their addictive nature, opioids continue to be a major treatment for pain due to a lack of effective alternatives. In an effort to boost new drugs, the FDA released new guidelines for non-opioid painkillers last week. But making these drugs hasn’t been easy. Vertex Pharmaceuticals received FDA approval for its non-opioid Journavx in January, then abandoned a next generation drug after a failed clinical trial earlier this summer. Acadia similarly abandoned a promising candidate after a failed trial in 2022. One possible basis for non-opioids might be cannabis. Earlier this year, researchers at Washington University at St. Louis and Stanford published a study showing that a cannabis-derived compound successfully eased pain in mice with minimal side effects. Munich-based pharmaceutical company Vertanical is perhaps the furthest along in this quest. It is developing a cannabinoid-based extract to treat chronic pain it hopes will soon become an approved medicine, first in the European Union and eventually in the United States. The drug, currently called Ver-01, packs enough low levels of cannabinoids (including THC) to relieve pain, but not so much that patients get high. Founder Clemens Fischer, a 50-year-old medical doctor and serial pharmaceutical and supplement entrepreneur, hopes it will become the first cannabis-based painkiller prescribed by physicians and covered by insurance. Fischer founded Vertanical, with his business partner Madlena Hohlefelder, in 2017, and has invested more than $250 million of his own money in it. With a cannabis cultivation site and drug manufacturing plant in Denmark, Vertanical has successfully passed phase III clinical trials in Germany and expects…
Share
BitcoinEthereumNews2025/09/18 05:26